217 related articles for article (PubMed ID: 17038126)
1. The management of osteoarthritis in the obese patient: practical considerations and guidelines for therapy.
Bliddal H; Christensen R
Obes Rev; 2006 Nov; 7(4):323-31. PubMed ID: 17038126
[TBL] [Abstract][Full Text] [Related]
2. [Osteoarthritis and obesity. Prognosis and treatment possibilities].
Bliddal H; Christensen RD
Ugeskr Laeger; 2006 Jan; 168(2):190-3. PubMed ID: 16403349
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of exercise and diet in the management of knee osteoarthritis in the obese].
Ghroubi S; Elleuch H; Kaffel N; Echikh T; Abid M; Elleuch MH
Ann Readapt Med Phys; 2008 Nov; 51(8):663-70. PubMed ID: 18952312
[TBL] [Abstract][Full Text] [Related]
4. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up.
Grotle M; Hagen KB; Natvig B; Dahl FA; Kvien TK
BMC Musculoskelet Disord; 2008 Oct; 9():132. PubMed ID: 18831740
[TBL] [Abstract][Full Text] [Related]
5. Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management.
Messier SP
Med Clin North Am; 2009 Jan; 93(1):145-59, xi-xii. PubMed ID: 19059026
[TBL] [Abstract][Full Text] [Related]
6. Obesity and symptomatic osteoarthritis of the knee.
Sridhar MS; Jarrett CD; Xerogeanes JW; Labib SA
J Bone Joint Surg Br; 2012 Apr; 94(4):433-40. PubMed ID: 22434455
[TBL] [Abstract][Full Text] [Related]
7. The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making.
Bliddal H; Christensen R
Expert Opin Pharmacother; 2009 Aug; 10(11):1793-804. PubMed ID: 19537998
[TBL] [Abstract][Full Text] [Related]
8. Strategies for the prevention and management of osteoarthritis of the hip and knee.
Bijlsma JW; Knahr K
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):59-76. PubMed ID: 17350544
[TBL] [Abstract][Full Text] [Related]
9. Obesity profiles with knee osteoarthritis: correlation with pain, disability, disease progression.
Marks R
Obesity (Silver Spring); 2007 Jul; 15(7):1867-74. PubMed ID: 17636106
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targets for osteoarthritis.
Edmonds S
Maturitas; 2009 Jul; 63(3):191-4. PubMed ID: 19423245
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle changes in the management of osteoarthritis.
O'Reilly S; Doherty M
Best Pract Res Clin Rheumatol; 2001 Oct; 15(4):559-68. PubMed ID: 11567539
[TBL] [Abstract][Full Text] [Related]
12. Obesity and knee arthroplasty.
Gillespie GN; Porteous AJ
Knee; 2007 Mar; 14(2):81-6. PubMed ID: 17188495
[TBL] [Abstract][Full Text] [Related]
13. Obesity: weight loss without drugs: a balanced diet avoiding high-calorie foods, plus exercise.
Prescrire Int; 2007 Aug; 16(90):162-7. PubMed ID: 17724845
[TBL] [Abstract][Full Text] [Related]
14. [Obesity: risk factor and predictor of osteoarthritis].
Grazio S; Balen D
Lijec Vjesn; 2009; 131(1-2):22-6. PubMed ID: 19348352
[TBL] [Abstract][Full Text] [Related]
15. [Osteoarthritis and obesity].
Sellam J; Berenbaum F
Rev Prat; 2012 May; 62(5):621-4. PubMed ID: 22730785
[TBL] [Abstract][Full Text] [Related]
16. Exercise and obesity.
Okay DM; Jackson PV; Marcinkiewicz M; Papino MN
Prim Care; 2009 Jun; 36(2):379-93. PubMed ID: 19501249
[TBL] [Abstract][Full Text] [Related]
17. Treatment modalities of obesity: what fits whom?
Hainer V; Toplak H; Mitrakou A
Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
[TBL] [Abstract][Full Text] [Related]
18. Obesity outcomes in disease management: clinical outcomes for osteoarthritis.
Nevitt MC
Obes Res; 2002 Nov; 10 Suppl 1():33S-37S. PubMed ID: 12446856
[No Abstract] [Full Text] [Related]
19. Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes.
Kelishadi R; Hashemipour M; Mohammadifard N; Alikhassy H; Adeli K
Clin Endocrinol (Oxf); 2008 Nov; 69(5):721-9. PubMed ID: 18284632
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
